- Home
- NTRB vs XTNT Comparison
NTRB vs XTNT Comparison
Compare NTRB & XTNT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NTRB
- XTNT
- Stock Information
- Founded
- NTRB 2016
- XTNT N/A
- Country
- NTRB United States
- XTNT United States
- Employees
- NTRB N/A
- XTNT N/A
- Industry
- NTRB Industrial Specialties
- XTNT Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- NTRB Health Care
- XTNT Health Care
- Exchange
- NTRB Nasdaq
- XTNT Nasdaq
- Market Cap
- NTRB 87.2M
- XTNT 89.8M
- IPO Year
- NTRB N/A
- XTNT N/A
- Fundamental
- Price
- NTRB N/A
- XTNT $0.77
- Analyst Decision
- NTRB Buy
- XTNT
- Analyst Count
- NTRB 1
- XTNT 0
- Target Price
- NTRB $13.00
- XTNT N/A
- AVG Volume (30 Days)
- NTRB 29.0K
- XTNT 206.2K
- Earning Date
- NTRB 12-03-2025
- XTNT 11-11-2025
- Dividend Yield
- NTRB N/A
- XTNT N/A
- EPS Growth
- NTRB N/A
- XTNT N/A
- EPS
- NTRB N/A
- XTNT N/A
- Revenue
- NTRB $2,578,059.00
- XTNT $127,766,000.00
- Revenue This Year
- NTRB $560.75
- XTNT $13.03
- Revenue Next Year
- NTRB $588.39
- XTNT N/A
- P/E Ratio
- NTRB N/A
- XTNT N/A
- Revenue Growth
- NTRB 42.92
- XTNT 15.16
- 52 Week Low
- NTRB $2.98
- XTNT $0.33
- 52 Week High
- NTRB $9.42
- XTNT $0.84
- Technical
- Relative Strength Index (RSI)
- NTRB 53.26
- XTNT 69.60
- Support Level
- NTRB $7.02
- XTNT $0.67
- Resistance Level
- NTRB $8.63
- XTNT $0.84
- Average True Range (ATR)
- NTRB 0.46
- XTNT 0.05
- MACD
- NTRB -0.01
- XTNT 0.01
- Stochastic Oscillator
- NTRB 39.87
- XTNT 71.82
About NTRB Nutriband Inc.
Nutriband Inc is engaged in the development of a portfolio of transdermal pharmaceutical products. AVERSA technology is the company's product that incorporates aversive agents to prevent the Abuse, Diversion, Misuse, and Accidental exposure of drugs with abuse potential specifically Opioids. The majority of the revenue is generated from the sale of goods that include consumer transdermal and coated products.
About XTNT Xtant Medical Holdings Inc.
Xtant Medical Holdings Inc is a medical technology company focused on the design, development, and commercialization of a comprehensive portfolio of orthobiologics and spinal implant systems to facilitate spinal fusion in complex spine, deformity and degenerative procedures. Its products are used by orthopedic spine surgeons and neurosurgeons to treat a variety of spinal disorders in the cervical, thoracolumbar, and interbody spine. The company's biomaterial products include OsteoSponge, OsteoSponge SC, OsteoSelect Plus DBM putty, OsteoWrap, and the line of 3Demin products, as well as other allografts. It generates a majority of its revenue from the U.S.